InfuSystem Holdings (INFU) Cost of Revenue (2010 - 2026)
InfuSystem Holdings' (INFU) quarterly Cost of Revenue came in at $14.0 million in Q1 2026, down 9.95% YoY from $15.5 million in Q1 2025, and down 11.35% on a QoQ basis from $15.8 million in Q4 2025.
InfuSystem Holdings (INFU) Cost of Revenue (2010 - 2026) Analysis & Trends
InfuSystem Holdings (INFU) has 17 years of Cost of Revenue data on file, last reported at $14.0 million in Q1 2026.
- Quarterly Cost of Revenue fell 9.95% year-over-year to $14.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $61.6 million (down 4.49% YoY) and the FY2025 annual result came in at $63.1 million, down 2.04% from the prior year.
- Cost of Revenue retreated to $14.0 million in Q1 2026, from $15.8 million in the prior quarter.
- In the past five years, Cost of Revenue ranged from a high of $17.0 million in Q2 2024 to a low of $11.1 million in Q3 2022.
- A 5-year average of $14.9 million and a median of $15.5 million in 2025 frame the typical range for Cost of Revenue.
- Annual changes were most pronounced in 2023 — Cost of Revenue soared 47.31% — and 2026, when it decreased 9.95%.
- Tracing INFU's Cost of Revenue over 5 years: stood at $14.8 million in 2022, then rose by 2.05% to $15.1 million in 2023, then climbed by 3.8% to $15.6 million in 2024, then climbed by 1.04% to $15.8 million in 2025, then declined by 11.35% to $14.0 million in 2026.
- The last three Cost of Revenue figures came in at $14.0 million (Q1 2026), $15.8 million (Q4 2025), and $15.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.50 Bn | 194.89 Bn | 7.27 Bn | 5.33 Bn |
| 2 | Stryker | 130.00 Bn | 126.52 Bn | 4.50 Bn | 2.09 Bn |
| 3 | Medtronic | 120.36 Bn | 111.14 Bn | 6.41 Bn | 3.40 Bn |
| 4 | Boston Scientific | 74.19 Bn | 73.65 Bn | 3.85 Bn | 1.59 Bn |
| 5 | Edwards Lifesciences | 52.73 Bn | 48.48 Bn | 1.35 Bn | 392.40 Mn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 478.40 Mn |
| 7 | GE HealthCare Technologies | 34.13 Bn | 32.02 Bn | 2.18 Bn | 2.25 Bn |
| 8 | Koninklijke Philips | 26.52 Bn | 23.20 Bn | 4.55 Bn | 2.57 Bn |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn | 808.60 Mn |
| 10 | InfuSystem Holdings | 245.89 Mn | 244.93 Mn | 21.41 Mn | 15.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 15.52 Mn |
| Jun 30, 2026 | 15.52 Mn |
| Mar 31, 2026 | 14.00 Mn |
| Mar 31, 2026 | 14.00 Mn |
| Dec 31, 2025 | 15.80 Mn |
| Dec 31, 2025 | 15.80 Mn |
| Sep 30, 2025 | 15.67 Mn |
| Sep 30, 2025 | 15.67 Mn |
| Jun 30, 2025 | 16.13 Mn |
| Jun 30, 2025 | 16.13 Mn |
| Mar 31, 2025 | 15.55 Mn |
| Mar 31, 2025 | 15.55 Mn |
| Dec 31, 2024 | 15.63 Mn |
| Dec 31, 2024 | 15.63 Mn |
| Sep 30, 2024 | 16.28 Mn |
| Sep 30, 2024 | 16.28 Mn |
| Jun 30, 2024 | 17.03 Mn |
| Jun 30, 2024 | 17.03 Mn |
| Mar 31, 2024 | 15.52 Mn |
| Mar 31, 2024 | 15.52 Mn |